These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15629612)

  • 1. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
    Cesaretti JA; Stock RG; Lehrer S; Atencio DA; Bernstein JL; Stone NN; Wallenstein S; Green S; Loeb K; Kollmeier M; Smith M; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):196-202. PubMed ID: 15629612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
    Cesaretti JA; Stock RG; Atencio DP; Peters SA; Peters CA; Burri RJ; Stone NN; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1410-6. PubMed ID: 17490827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATM missense variant P1054R predisposes to prostate cancer.
    Meyer A; Wilhelm B; Dörk T; Bremer M; Baumann R; Karstens JH; Machtens S
    Radiother Oncol; 2007 Jun; 83(3):283-8. PubMed ID: 17502119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.
    Andreassen CN; Overgaard J; Alsner J; Overgaard M; Herskind C; Cesaretti JA; Atencio DP; Green S; Formenti SC; Stock RG; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):776-83. PubMed ID: 16338099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
    Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy.
    Ho AY; Fan G; Atencio DP; Green S; Formenti SC; Haffty BG; Iyengar P; Bernstein JL; Stock RG; Cesaretti JA; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):677-84. PubMed ID: 17517479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients.
    Pugh TJ; Keyes M; Barclay L; Delaney A; Krzywinski M; Thomas D; Novik K; Yang C; Agranovich A; McKenzie M; Morris WJ; Olive PL; Marra MA; Moore RA
    Clin Cancer Res; 2009 Aug; 15(15):5008-16. PubMed ID: 19638463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.
    Ho AY; Atencio DP; Peters S; Stock RG; Formenti SC; Cesaretti JA; Green S; Haffty B; Drumea K; Leitzin L; Kuten A; Azria D; Ozsahin M; Overgaard J; Andreassen CN; Trop CS; Park J; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):646-55. PubMed ID: 16751059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy.
    Meyer A; John E; Dörk T; Sohn C; Karstens JH; Bremer M
    Radiother Oncol; 2004 Sep; 72(3):319-23. PubMed ID: 15450731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects.
    Iannuzzi CM; Atencio DP; Green S; Stock RG; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):606-13. PubMed ID: 11849780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls.
    Buchholz TA; Weil MM; Ashorn CL; Strom EA; Sigurdson A; Bondy M; Chakraborty R; Cox JD; McNeese MD; Story MD
    Cancer; 2004 Apr; 100(7):1345-51. PubMed ID: 15042666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic cellular characterization of an ataxia telangiectasia patient carrying a causal homozygous missense mutation.
    Angèle S; Laugé A; Fernet M; Moullan N; Beauvais P; Couturier J; Stoppa-Lyonnet D; Hall J
    Hum Mutat; 2003 Feb; 21(2):169-70. PubMed ID: 12552566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant irradiation in breast cancer patients with ATM gene heterozygous mutations: special focus on clinical efficacy/toxicity].
    Chargari C; Kirova YM; Even C; Monnier L; Dendale R; Campana F; Fourquet A
    Cancer Radiother; 2009 Jun; 13(3):164-72. PubMed ID: 19162519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of sequence alterations in the ATM gene.
    Lavin MF; Scott S; Gueven N; Kozlov S; Peng C; Chen P
    DNA Repair (Amst); 2004; 3(8-9):1197-205. PubMed ID: 15279808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM variants and cancer risk in breast cancer patients from Southern Finland.
    Tommiska J; Jansen L; Kilpivaara O; Edvardsen H; Kristensen V; Tamminen A; Aittomäki K; Blomqvist C; Børresen-Dale AL; Nevanlinna H
    BMC Cancer; 2006 Aug; 6():209. PubMed ID: 16914028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.
    Offit K; Gilad S; Paglin S; Kolachana P; Roisman LC; Nafa K; Yeugelewitz V; Gonzales M; Robson M; McDermott D; Pierce HH; Kauff ND; Einat P; Jhanwar S; Satagopan JM; Oddoux C; Ellis N; Skaliter R; Yahalom J
    Clin Cancer Res; 2002 Dec; 8(12):3813-9. PubMed ID: 12473594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling ATM mutant proteins from missense changes confirms retained kinase activity.
    Barone G; Groom A; Reiman A; Srinivasan V; Byrd PJ; Taylor AM
    Hum Mutat; 2009 Aug; 30(8):1222-30. PubMed ID: 19431188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.